Manufacturing News of Note—Taro recalls seizure drugs; explosions at API plant  

A closeup of a stock market ticker
(Pixabay)

> Taro Pharmaceuticals is voluntarily recalling two lots of phenytoin oral suspension USP, 125 mg/5 mL both in 237 mL bottles, to the consumer level because they may not re-suspend when shaken, potentially leading to dosing issues. Release 

> The Massachusetts State Fire Marshal determined that several explosions Feb. 13 at a PCI Synthesis API plant in Newburyport occurred during a sampling procedure. No one was injured. Release  

> Catalent Pharma Solutions will offer nearly $500 million in senior unsecured notes due 2028. Release 

Survey

Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

> Italy-based CDMO and API maker Dipharma has completed a new quality control laboratory and kilolab at its CDMO site in Kalamazoo, Michigan. Release

Suggested Articles

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

As flights from China contract and prices double, the logistics of getting products out of China is a major challenge. 

A group of drugmakers and others say some federal policies to fight COVID-19 are it making more expensive and harder to get some drugs.